Association of kidney function with incident hip fracture in older adults.

PubWeight™: 1.92‹?› | Rank: Top 3%

🔗 View Article (PMID 17167115)

Published in J Am Soc Nephrol on December 13, 2006

Authors

Linda F Fried1, Mary Louise Biggs, Michael G Shlipak, Stephen Seliger, Bryan Kestenbaum, Catherine Stehman-Breen, Mark Sarnak, David Siscovick, Tamara Harris, Jane Cauley, Anne B Newman, John Robbins

Author Affiliations

1: VA Pittsburgh Healthcare System, Pittsburgh, PA 15240, USA. linda.fried@med.va.gov

Associated clinical trials:

Trial of Pirfenidone to Prevent Progression in Chronic Kidney Disease (TOP-CKD) | NCT04258397

Articles citing this

Cystatin C identifies chronic kidney disease patients at higher risk for complications. J Am Soc Nephrol (2010) 3.85

Timing of onset of CKD-related metabolic complications. J Am Soc Nephrol (2008) 2.60

Partial versus radical nephrectomy for 4 to 7 cm renal cortical tumors. J Urol (2009) 2.05

Chronic kidney disease and bone fracture: a growing concern. Kidney Int (2008) 1.76

Rapid cortical bone loss in patients with chronic kidney disease. J Bone Miner Res (2013) 1.74

Cystatin C and risk of hip fractures in older women. J Bone Miner Res (2013) 1.54

Pancreas-kidney transplantation is associated with reduced fracture risk compared with kidney-alone transplantation in men with type 1 diabetes. Kidney Int (2013) 1.48

Fracture Burden and Risk Factors in Childhood CKD: Results from the CKiD Cohort Study. J Am Soc Nephrol (2015) 1.47

Bone mass and microarchitecture in CKD patients with fracture. J Am Soc Nephrol (2010) 1.26

Cystatin-C, renal function, and incidence of hip fracture in postmenopausal women. J Am Geriatr Soc (2008) 1.24

Renal function and rate of hip bone loss in older men: the Osteoporotic Fractures in Men Study. Osteoporos Int (2008) 1.20

Bone mineral density and fracture risk in older individuals with CKD. Clin J Am Soc Nephrol (2012) 1.18

CKD as an underrecognized threat to patient safety. Am J Kidney Dis (2009) 1.14

The effect of raloxifene treatment in postmenopausal women with CKD. J Am Soc Nephrol (2008) 1.13

The French Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort study. Nephrol Dial Transplant (2013) 1.12

Increased risk of hip fracture among Japanese hemodialysis patients. J Bone Miner Metab (2013) 1.11

Association of cystatin C with adverse outcomes. Curr Opin Nephrol Hypertens (2009) 1.11

Discriminants of prevalent fractures in chronic kidney disease. J Am Soc Nephrol (2011) 1.05

Inflammatory markers and the risk of hip fracture: the Women's Health Initiative. J Bone Miner Res (2012) 1.05

Association of serum intact parathyroid hormone with lower estimated glomerular filtration rate. Clin J Am Soc Nephrol (2008) 1.01

Aging and chronic kidney disease: the impact on physical function and cognition. J Gerontol A Biol Sci Med Sci (2013) 1.01

Fracture risk assessment in patients with chronic kidney disease. Osteoporos Int (2011) 0.99

Homocysteine levels and risk of hip fracture in postmenopausal women. J Clin Endocrinol Metab (2009) 0.98

Inflammatory markers and risk of hip fracture in older white women: the study of osteoporotic fractures. J Bone Miner Res (2014) 0.95

Renal function and nonvertebral fracture risk in multiethnic women: the Women's Health Initiative (WHI). Osteoporos Int (2011) 0.92

Current status of bicarbonate in CKD. J Am Soc Nephrol (2014) 0.91

Cortical bone mechanical properties are altered in an animal model of progressive chronic kidney disease. PLoS One (2014) 0.91

Estimated GFR and risk of hip fracture in older men: comparison of associations using cystatin C and creatinine. Am J Kidney Dis (2013) 0.91

A structural approach to skeletal fragility in chronic kidney disease. Semin Nephrol (2009) 0.90

The clinical utility of FRAX to discriminate fracture status in men and women with chronic kidney disease. Osteoporos Int (2013) 0.87

Potential explanatory factors for higher incident hip fracture risk in older diabetic adults. Curr Gerontol Geriatr Res (2011) 0.85

Fibroblast growth factor 23, bone mineral density, and risk of hip fracture among older adults: the cardiovascular health study. J Clin Endocrinol Metab (2013) 0.85

Estimated GFR and fracture risk: a population-based study. Clin J Am Soc Nephrol (2013) 0.84

Use of renal function measurements for assessing fracture risk in postmenopausal women. Mayo Clin Proc (2008) 0.82

Comparison of fracture risk prediction among individuals with reduced and normal kidney function. Clin J Am Soc Nephrol (2015) 0.80

Chronic kidney disease and the skeleton. Bone Res (2014) 0.79

Fracture risk in CKD. Clin J Am Soc Nephrol (2013) 0.79

Cystatin C: a new renal marker and its potential use in small animal medicine. J Vet Intern Med (2014) 0.79

Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients. BMC Nephrol (2012) 0.79

The effect of combined calcium and cholecalciferol supplementation on bone mineral density in elderly women with moderate chronic kidney disease. Clin Nephrol (2012) 0.79

Comparative evaluation of essential and toxic elements in the blood of kidney failure patients and healthy referents. Environ Monit Assess (2015) 0.79

Trabecular Bone Score and Incident Fragility Fracture Risk in Adults with Reduced Kidney Function. Clin J Am Soc Nephrol (2016) 0.78

Effects of cinacalcet on bone mineral density and bone markers in hemodialysis patients with secondary hyperparathyroidism. Clin Exp Nephrol (2012) 0.77

Change in estimated glomerular filtration rate and fracture risk in the Action to Control Cardiovascular Risk in Diabetes Trial. Bone (2015) 0.77

Chronic Kidney Disease-Mineral Bone Disorder in Korean Patients: a Report from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD). J Korean Med Sci (2017) 0.75

Association of Increased Urinary Albumin with Risk of Incident Clinical Fracture and Rate of Hip Bone Loss: The Osteoporotic Fractures in Men Study. J Bone Miner Res (2016) 0.75

Can one evaluate bone disease in chronic kidney disease without a biopsy? Curr Opin Nephrol Hypertens (2014) 0.75

Safety and effectiveness of daily teriparatide for osteoporosis in patients with severe stages of chronic kidney disease: post hoc analysis of a postmarketing observational study. Clin Interv Aging (2016) 0.75

Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study. PLoS One (2016) 0.75

Effects of raloxifene on bone metabolism in hemodialysis patients. Int J Endocrinol Metab (2012) 0.75

Decreased cortical thickness, as estimated by a newly developed ultrasound device, as a risk for vertebral fracture in type 2 diabetes mellitus patients with eGFR of less than 60 mL/min/1.73 m2. Osteoporos Int (2014) 0.75

Molecular Abnormalities Underlying Bone Fragility in Chronic Kidney Disease. Biomed Res Int (2017) 0.75

Effects of klotho deletion from bone during chronic kidney disease. Bone (2017) 0.75

Inhibition of GSK-3β increases trabecular bone volume but not cortical bone volume in adenine-induced uremic mice with severe hyperparathyroidism. Physiol Rep (2016) 0.75

Chronic kidney disease and small renal tumors: What urologists should know? Indian J Urol (2009) 0.75

Low holotranscobalamin and cobalamins predict incident fractures in elderly men: the MrOS Sweden. Osteoporos Int (2013) 0.75

Dietary acid load, trabecular bone integrity, and mineral density in an ageing population: the Rotterdam study. Osteoporos Int (2017) 0.75

An Increased Rate of Fracture Occurs a Decade Earlier in HIV+ Compared to HIV- men in the Multicenter AIDS Cohort Study (MACS). AIDS (2017) 0.75

Articles by these authors

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA (2004) 23.69

Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation (2010) 19.30

Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med (2005) 15.30

Gait speed and survival in older adults. JAMA (2011) 15.01

Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 12.44

Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet (2009) 12.19

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet (2012) 12.10

Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med (2006) 12.09

Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men. Contemp Clin Trials (2005) 9.57

Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet (2010) 8.89

Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med (2006) 8.73

Estrogen therapy and coronary-artery calcification. N Engl J Med (2007) 8.70

Exemestane for breast-cancer prevention in postmenopausal women. N Engl J Med (2011) 8.19

The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci (2006) 7.38

Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med (2009) 7.06

Association of usual sleep duration with hypertension: the Sleep Heart Health Study. Sleep (2006) 6.98

Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc (2006) 6.81

Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res (2007) 6.76

Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study. J Am Geriatr Soc (2005) 6.73

Effects of a physical activity intervention on measures of physical performance: Results of the lifestyle interventions and independence for Elders Pilot (LIFE-P) study. J Gerontol A Biol Sci Med Sci (2006) 6.61

Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med (2006) 6.58

Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis (2009) 6.54

Prognostic value of usual gait speed in well-functioning older people--results from the Health, Aging and Body Composition Study. J Am Geriatr Soc (2005) 6.54

Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 6.51

Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med (2010) 6.47

Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. J Gerontol A Biol Sci Med Sci (2005) 6.42

Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA (2011) 6.10

Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med (2002) 5.98

Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc (2011) 5.96

Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation (2010) 5.70

New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58

Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48

Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA (2005) 5.46

Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis (2010) 5.35

Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int (2011) 5.25

Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA (2010) 5.20

Inactivating mutations in NPC1L1 and protection from coronary heart disease. N Engl J Med (2014) 4.94

The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study. Ann Intern Med (2010) 4.89

Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet (2009) 4.78

A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet (2008) 4.75

The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA (2004) 4.73

Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation (2003) 4.67

The relative safety of ephedra compared with other herbal products. Ann Intern Med (2003) 4.65

Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med (2005) 4.57

Leg muscle mass and composition in relation to lower extremity performance in men and women aged 70 to 79: the health, aging and body composition study. J Am Geriatr Soc (2002) 4.55

The 6-min walk test: a quick measure of functional status in elderly adults. Chest (2003) 4.29

Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol (2003) 4.28

Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care (2003) 4.23

Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch Intern Med (2005) 4.11

Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation (2003) 4.09

Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes (2010) 4.07

Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA (2003) 4.07

Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci (2002) 4.00

Cystatin C identifies chronic kidney disease patients at higher risk for complications. J Am Soc Nephrol (2010) 3.85

Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol (2006) 3.85

Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet (2012) 3.71

Cognitive function, gait speed decline, and comorbidities: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci (2007) 3.61

Depression and cardiovascular sequelae in postmenopausal women. The Women's Health Initiative (WHI). Arch Intern Med (2004) 3.59

Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med (2005) 3.56

Rapid kidney function decline and mortality risk in older adults. Arch Intern Med (2008) 3.54

Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative. Arch Intern Med (2010) 3.53

Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol (2011) 3.53

Limited literacy and mortality in the elderly: the health, aging, and body composition study. J Gen Intern Med (2006) 3.51

Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr (2009) 3.44

Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet (2011) 3.40

Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study. Arch Intern Med (2005) 3.39

Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation (2006) 3.31

Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol (2005) 3.28

Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med (2007) 3.27

A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep AHEAD study. Arch Intern Med (2009) 3.27

Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med (2009) 3.24

Association between lower digit symbol substitution test score and slower gait and greater risk of mortality and of developing incident disability in well-functioning older adults. J Am Geriatr Soc (2008) 3.21

Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21

Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev (2005) 3.20

Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol (2005) 3.14

A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study. Arch Intern Med (2005) 3.14

Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA (2002) 3.13

Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am Soc Nephrol (2009) 3.12

Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study. AIDS (2009) 3.12